# Workflow 5: Plasmodium Artemisinin Resistance - Target Discovery & Next-Generation Antimalarials

**Paper**: "Selective inhibition of Plasmodium falciparum ATPase 6 by artemisinins and identification of new antimalarial targets"

## Research Objective

- Characterize artemisinin resistance mechanisms and ATPase6 mutations
- Identify new antimalarial targets to overcome resistance through comparative genomics
- Design next-generation antimalarials with novel mechanisms of action
- Enable rational development of drugs against artemisinin-resistant strains

## Quick Reference

| Parameter | Value | Notes |
|-----------|-------|-------|
| **Runtime** | 8-12 weeks | End-to-end from genomic analysis through inhibitor design |
| **Storage Required** | 400 GB | Genomic databases, docking calculations, MD trajectories |
| **CPU Cores** | 16-24 | Parallel docking/MD simulations, virtual screening |
| **GPU Required** | 2× Tesla V100 (optional) | GROMACS MD simulations, deep docking |
| **Success Metrics** | Novel targets identified (3-5), inhibitors with IC₅₀ <100 nM, >100-fold selectivity vs human orthologs |
| **Cost Estimate** | $15,000-22,000 | HPC time, software licenses, database access |

## Installation & Setup

```bash
# Create conda environment
conda create -n plasmo_resistance python=3.10 biopython blast+ raxml iqtree -y
conda activate plasmo_resistance

# Install molecular docking and analysis tools
pip install autodock-vina meeko openbabel-wheel numpy pandas scipy scikit-learn matplotlib seaborn

# Install structure analysis tools
pip install prody foldx rosetta

# Install specialized tools
pip install rdkit zinc-api chembl-webresource-client

# Optional: Install GROMACS for MD simulations
conda install -c conda-forge gromacs -y

# Verify installations
python -c "import Bio, RDKit, prody; print('✓ Core dependencies installed')"
which vina AutoDock4
echo "Setup complete!"
```

---

## STEP 1: Target Identification and Resistance Mutation Analysis

**OBJECTIVE**: Characterize PfATPase6 mutations in artemisinin-resistant parasites, determine functional impact and resistance mechanism, establish baseline for new target identification.

**INPUT SPECS**:
- Plasmodium falciparum genomic sequences (100+ resistant strains from endemic regions)
- Reference PfATPase6 sequence (GenBank: PF3D7_0323200)
- Known artemisinin-resistant populations data
- Human ATP synthase sequence (for ortholog comparison)
- File format: Multi-FASTA (.fa), tab-delimited mutation databases

**CODE BLOCK - Resistance Mutation Analysis**:

```python
from Bio import SeqIO, Phylo, Align
import pandas as pd
import subprocess
import matplotlib.pyplot as plt
from collections import Counter

# Step 1.1: BLAST resistant genomes against PfATPase6 reference
reference_atp6 = "PfATPase6_reference.fasta"
resistant_genomes_dir = "resistant_genomes/"

mutation_data = []

for genome_file in os.listdir(resistant_genomes_dir):
    strain_id = genome_file.replace(".fasta", "")
    
    # Local BLAST search
    blast_db = f"blast_db/{strain_id}"
    subprocess.run([
        "makeblastdb", "-in", f"{resistant_genomes_dir}{genome_file}",
        "-dbtype", "nucl", "-out", blast_db
    ], capture_output=True)
    
    # BLAST query
    blast_result = f"blast_results/{strain_id}.xml"
    subprocess.run([
        "blastn", "-query", reference_atp6, f"-db", blast_db,
        "-outfmt", "5", "-out", blast_result, "-evalue", "1e-10"
    ], capture_output=True)
    
    # Parse BLAST to align and call mutations
    for record in SeqIO.parse(blast_result, "blast-xml"):
        for alignment in record.alignments:
            for hsp in alignment.hsps:
                ref_seq = hsp.query
                query_seq = hsp.sbjct
                
                # Call SNPs and indels
                mutations = []
                for i, (ref_aa, mut_aa) in enumerate(zip(ref_seq, query_seq)):
                    if ref_aa != mut_aa and ref_aa != '-' and mut_aa != '-':
                        mutations.append({
                            'strain': strain_id,
                            'position': i + 1,
                            'ref_aa': ref_aa,
                            'mut_aa': mut_aa,
                            'mutation': f"{ref_aa}{i+1}{mut_aa}"
                        })
                mutation_data.extend(mutations)

mutations_df = pd.DataFrame(mutation_data)

# Step 1.2: Mutation frequency and distribution
mutation_counts = mutations_df.groupby('mutation').size().sort_values(ascending=False)
print(f"Total unique mutations: {len(mutation_counts)}")
print(f"Known resistance mutation L263E: {(mutation_counts.get('L263E', 0) / len(mutations_df['strain'].unique())) * 100:.1f}% strains")

# Step 1.3: Position conservation analysis using Shannon entropy
position_entropies = {}
for pos in mutations_df['position'].unique():
    pos_mutations = mutations_df[mutations_df['position'] == pos]['mut_aa'].tolist()
    aa_counts = Counter(pos_mutations)
    total = len(pos_mutations)
    entropy = -sum((count/total) * np.log2(count/total) for count in aa_counts.values() if count > 0)
    position_entropies[pos] = entropy

# High-entropy positions = mutation hotspots
hotspot_threshold = np.percentile(list(position_entropies.values()), 75)
hotspots = [pos for pos, entropy in position_entropies.items() if entropy > hotspot_threshold]
print(f"Resistance hotspots (entropy>{hotspot_threshold:.2f}): {sorted(hotspots)}")

# Step 1.4: Phylogenetic relationship of resistant strains
# Align all PfATPase6 sequences from resistant strains
aligner = Align.PairwiseAligner()
alignments = []
for mutation_group in mutations_df.groupby('strain'):
    # Build consensus sequence with mutations
    alignments.append((mutation_group[0], mutation_group[1]))

# Build phylogenetic tree with RAxML
subprocess.run([
    "raxmlHPC", "-m", "PROTGAMMAAUTO", "-p", "12345",
    "-x", "12345", "-#", "100",
    "-s", "aligned_atp6.phy", "-n", "resistance_tree",
    "-q", "model_partitions.txt", "-T", "8"
], capture_output=True)

print("✓ Resistance mutation analysis complete")
print(f"  - {len(mutations_df)} mutations identified across {len(mutations_df['strain'].unique())} resistant strains")
print(f"  - {len(hotspots)} hotspot positions identified")
```

**OUTPUT SPECS**:
- Mutations dataframe (CSV): strain ID, position, ref amino acid, mutant amino acid, frequency
- Hotspot positions (JSON): position, entropy score, mutation types, frequency distribution
- Phylogenetic tree (NEWICK): resistance strain relationships
- Metrics: mutation frequency distribution, hotspot entropy scores, phylogenetic support values
- Expected: 50-200 unique mutations identified, 5-15 hotspot positions, clear phylogenetic clusters

**VALIDATION SCRIPT**:

```python
# Validate mutation calling and hotspot identification
assert len(mutations_df) > 50, "Insufficient mutations identified"
assert len(hotspots) > 3, "Insufficient hotspot positions"
assert mutations_df['strain'].nunique() > 20, "Insufficient strain diversity"

# Validate known resistance mutations present
known_resistance_muts = ['L263E', 'L263K', 'S769N', 'E1312K']
found_muts = [mut for mut in known_resistance_muts if mut in mutation_counts.index]
assert len(found_muts) > 0, f"Known resistance mutations not found: {known_resistance_muts}"

print(f"✓ Known resistance mutations found: {', '.join(found_muts)}")
print(f"✓ Strain phylogeny supported by {len(phylo_clusters)} clades")
```

**SUCCESS CRITERIA**:
- ✅ Minimum 50 unique mutations identified from resistant strains
- ✅ Known resistance mutations (L263E, L263K, S769N) present in dataset
- ✅ Mutation frequency >25% for known resistance hotspots
- ✅ Phylogenetic tree shows clear clustering by resistance phenotype
- ✅ Hotspot entropy scores >0.8 bits

**NEXT STEP**: Use characterized mutations to analyze artemisinin binding and mechanism of resistance (STEP 2)

---

## STEP 2: Artemisinin Binding Mode Analysis and Resistance Mechanism

**OBJECTIVE**: Determine how resistance mutations alter artemisinin binding to PfATPase6, quantify binding affinity changes, predict selectivity vs human ortholog.

**INPUT SPECS**:
- PfATPase6 structure (PDB: 5HFU, or AlphaFold2 model)
- Human ATP synthase F0-F1 structure (PDB: 6YMP, for ortholog comparison)
- Artemisinin 3D structure (SMILES from ChEMBL: CC1=C2CC(=O)C3=C(O2)OO3)
- Resistance mutations from STEP 1 (hotspot positions)
- Artemisinin derivatives for selectivity analysis

**CODE BLOCK - Binding Analysis**:

```python
from Bio.PDB import PDBParser, PDBIO, Superimposer
import subprocess
import json
from rdkit import Chem, AllChem
from rdkit.Chem import Descriptors, Crippen

# Step 2.1: Prepare ATPase6 structure and mutations
pdb_parser = PDBParser(QUIET=True)
pf_struct = pdb_parser.get_structure('PfATPase6', 'PfATPase6_wildtype.pdb')
human_struct = pdb_parser.get_structure('hATPase6', 'human_ATP_synthase.pdb')

# Extract ATP6 subunit from PfATPase6 complex
pf_atp6_chain = pf_struct[0]['B']  # ATP6 is chain B

# Step 2.2: Generate resistance mutants
mutation_hotspots_from_step1 = [263, 338, 484, 769, 1312]  # Example hotspots
mutations_to_test = [
    ('263', 'L', 'E'), ('263', 'L', 'K'),  # Known resistance mutations
    ('338', 'S', 'T'),
    ('484', 'D', 'Y'),
    ('769', 'S', 'N')
]

for wt_pos, wt_aa, mut_aa in mutations_to_test:
    mutant_pdb = f"PfATPase6_L{wt_pos}{mut_aa}.pdb"
    
    # Use FoldX for rapid mutation modeling
    subprocess.run([
        "foldx", "--command=BuildModel",
        f"--pdb=PfATPase6_wildtype.pdb",
        f"--mutant=mutant.txt",  # Contains: chainB, wt_pos, mut_aa
        f"--output-file={mutant_pdb}"
    ], capture_output=True)

# Step 2.3: Prepare artemisinin ligand
artemisinin_smiles = "CC1=C2CC(=O)C3=C(O2)OO3"  # Artemisinin core
artemisinin_mol = Chem.MolFromSmiles(artemisinin_smiles)
artemisinin_3d = AllChem.AddHs(artemisinin_mol)
AllChem.EmbedMolecule(artemisinin_3d, randomSeed=42)
AllChem.MMFFOptimizeMolecule(artemisinin_3d)

# Convert to PDB for docking
from rdkit.Chem import AllChem
artemisinin_pdb = "artemisinin.pdb"
writer = Chem.SDWriter(artemisinin_pdb)
writer.write(artemisinin_3d)

# Step 2.4: Molecular docking with AutoDock
docking_results = []

for struct_name in ['wildtype'] + [f"L263{mut}" for _, _, mut in mutations_to_test]:
    receptor_pdb = f"PfATPase6_{struct_name}.pdb"
    
    # Prepare PDBQT files
    subprocess.run([
        "prepare_receptor4.py", "-r", receptor_pdb,
        "-o", receptor_pdb.replace('.pdb', '.pdbqt')
    ], capture_output=True)
    
    subprocess.run([
        "prepare_ligand4.py", "-l", artemisinin_pdb,
        "-o", artemisinin_pdb.replace('.pdb', '.pdbqt')
    ], capture_output=True)
    
    # Define binding site (ATP binding pocket: residues 200-350)
    binding_center_x, binding_center_y, binding_center_z = 42.0, 15.5, 31.0
    box_size = 30  # Ångströms
    
    # Run AutoDock Vina
    output_dlg = f"docking_{struct_name}.dlg"
    cmd = f"""vina --receptor {receptor_pdb.replace('.pdb', '.pdbqt')} \
            --ligand {artemisinin_pdb.replace('.pdb', '.pdbqt')} \
            --center_x {binding_center_x} --center_y {binding_center_y} --center_z {binding_center_z} \
            --size_x {box_size} --size_y {box_size} --size_z {box_size} \
            --exhaustiveness 8 --num_modes 10 \
            --out {output_dlg.replace('.dlg', '.pdbqt')}"""
    
    result = subprocess.run(cmd, shell=True, capture_output=True, text=True)
    
    # Parse docking output
    for line in result.stdout.split('\n'):
        if 'RESULT:' in line:
            affinity_kcal = float(line.split()[2])
            docking_results.append({
                'structure': struct_name,
                'affinity_kcal_mol': affinity_kcal,
                'Ki_nM': np.exp((affinity_kcal * 1000 * 4.184) / (8.314 * 298)) * 1e9  # Van't Hoff
            })

docking_df = pd.DataFrame(docking_results)

# Step 2.5: Selectivity analysis - PfATPase6 vs human ATP synthase
# Repeat docking against human ATP synthase to assess selectivity
print("\n=== BINDING AFFINITY COMPARISON ===")
wt_affinity = docking_df[docking_df['structure'] == 'wildtype']['affinity_kcal_mol'].values[0]
print(f"Wildtype PfATPase6 affinity: {wt_affinity:.2f} kcal/mol ({docking_df.loc[0, 'Ki_nM']:.1f} nM)")

for idx, row in docking_df.iterrows():
    if row['structure'] != 'wildtype':
        delta_g = row['affinity_kcal_mol'] - wt_affinity
        fold_change = 2**(delta_g / 1.36)  # Converting kcal/mol to fold change
        print(f"{row['structure']}: {row['affinity_kcal_mol']:.2f} kcal/mol ({row['Ki_nM']:.1f} nM) - "
              f"Δ{delta_g:+.2f} kcal/mol ({fold_change:+.1f}× binding change)")

# Step 2.6: Selectivity scoring vs human ortholog
selectivity_ratios = []
for struct in docking_df['structure'].unique():
    pf_ki = docking_df[docking_df['structure'] == struct]['Ki_nM'].values[0]
    
    # Dock to human ATP synthase
    human_output_dlg = f"docking_human_{struct}.dlg"
    # [Run similar docking against human structure - code similar to above]
    # Get human Ki (assumed from previous docking)
    
    selectivity = human_ki / pf_ki  # Ratio - higher = more selective for Pf
    selectivity_ratios.append({
        'structure': struct,
        'selectivity_ratio': selectivity
    })

selectivity_df = pd.DataFrame(selectivity_ratios)
print(f"\n=== SELECTIVITY RATIOS (Human/Pf) ===")
print(selectivity_df.to_string(index=False))

# Step 2.7: Resistance mechanism interpretation
print("\n=== RESISTANCE MECHANISM ===")
resistance_muts = ['L263E', 'L263K', 'S769N']
for mut_name in resistance_muts:
    mut_data = docking_df[docking_df['structure'] == mut_name]
    if not mut_data.empty:
        affinity_loss = mut_data['affinity_kcal_mol'].values[0] - wt_affinity
        print(f"{mut_name}: {affinity_loss:+.2f} kcal/mol loss in artemisinin binding → RESISTANCE MECHANISM")

print("✓ Binding mode analysis complete")
```

**OUTPUT SPECS**:
- Docking results (CSV): structure, binding affinity (kcal/mol), Ki (nM), selectivity ratio vs human
- Binding poses (PDB files): top 5 poses for each structure
- Selectivity report (JSON): PfATPase6 Ki, human ATP synthase Ki, selectivity ratio, fold-change in binding
- Metrics: binding affinity ΔΔG for each mutation, selectivity ratios, resistance mechanism correlation
- Expected: 0.5-2.5 kcal/mol affinity loss for resistance mutations, >100-fold selectivity for Pf

**VALIDATION SCRIPT**:

```python
# Validate binding calculations
assert len(docking_df) >= 5, "Insufficient docking results"
assert 'affinity_kcal_mol' in docking_df.columns, "Missing affinity column"
assert 'Ki_nM' in docking_df.columns, "Missing Ki calculation"

# Validate resistance mutation binding loss
resistance_affinity_loss = []
for mut in ['L263E', 'L263K', 'S769N']:
    mut_row = docking_df[docking_df['structure'] == mut]
    if not mut_row.empty:
        loss = mut_row['affinity_kcal_mol'].values[0] - docking_df[docking_df['structure'] == 'wildtype']['affinity_kcal_mol'].values[0]
        resistance_affinity_loss.append(loss)

assert len(resistance_affinity_loss) > 0, "No resistance mutations evaluated"
assert np.mean(resistance_affinity_loss) > 0.3, "Insufficient binding loss for resistance mutations"

print(f"✓ Binding affinity loss for resistance mutations: {np.mean(resistance_affinity_loss):.2f} kcal/mol")
print(f"✓ Selectivity maintained >10-fold for {len(selectivity_df[selectivity_df['selectivity_ratio'] > 10])} structures")
```

**SUCCESS CRITERIA**:
- ✅ Binding affinity calculated for wildtype and 5+ mutant structures
- ✅ Resistance mutations show ≥0.5 kcal/mol affinity loss
- ✅ Selectivity ratio ≥100-fold for Pf vs human ortholog (wildtype)
- ✅ Clear correlation between known resistance mutations and artemisinin binding loss
- ✅ Ki values in realistic range for known inhibitors (1-1000 nM)

**NEXT STEP**: Use binding mechanism insights to identify new targets with reduced resistance potential (STEP 3)

---

## STEP 3: New Antimalarial Target Mining and Validation

**OBJECTIVE**: Identify essential Plasmodium genes not targeted by artemisinin, assess druggability and selectivity vs human orthologs, validate against known resistance mechanisms.

**INPUT SPECS**:
- Plasmodium falciparum essential genes database (PlasmoDB)
- Human orthologs database (Ensembl/UniProt)
- Structure predictions (AlphaFold2 for all targets)
- Artemisinin resistance profile from STEP 2
- Gene expression data from resistant strains (RNA-seq or microarray)

**CODE BLOCK - Target Mining**:

```python
import requests
import json
from Bio import SeqIO, SwissProt
import subprocess

# Step 3.1: Retrieve Plasmodium essential genes
print("=== TARGET MINING ===")
print("Retrieving Plasmodium falciparum essential genes from PlasmoDB...")

# Query PlasmoDB API for essential genes with GO terms related to parasite viability
plasmo_essential_genes = []
go_terms_parasite_essential = ['GO:0009267', 'GO:0015986', 'GO:0003674']  # Cell viability, ATP synthase

for go_term in go_terms_parasite_essential:
    url = f"https://plasmodb.org/api/gene-text-search"
    params = {
        'text': go_term,
        'q': f'(organism_text:\"Plasmodium falciparum\") AND (go_term:\"{go_term}\")',
        'type': 'gene'
    }
    
    # [API call to PlasmoDB]
    # For this example, load from local database
    with open('plasmodb_essential_genes.json') as f:
        essential_data = json.load(f)
        plasmo_essential_genes.extend(essential_data['genes'])

essential_genes_df = pd.DataFrame(plasmo_essential_genes)
print(f"Retrieved {len(essential_genes_df)} essential Plasmodium genes")

# Step 3.2: Identify human orthologs using bidirectional BLAST
print("\nIdentifying human orthologs...")

# Create BLAST databases
human_fasta = "human_proteins.fasta"
pf_fasta = "plasmodium_proteins.fasta"

subprocess.run(["makeblastdb", "-in", pf_fasta, "-dbtype", "prot", "-out", "pf_db"],
              capture_output=True)
subprocess.run(["makeblastdb", "-in", human_fasta, "-dbtype", "prot", "-out", "human_db"],
              capture_output=True)

orthologs = []
for gene in essential_genes_df['gene_id'].tolist()[:100]:  # Screen first 100 genes
    # BLAST Pf protein against human database
    pf_seq_file = f"sequences/{gene}.fasta"
    
    result = subprocess.run([
        "blastp", "-query", pf_seq_file, "-db", "human_db",
        "-evalue", "1e-10", "-outfmt", "6"
    ], capture_output=True, text=True)
    
    # Parse hits
    if result.stdout:
        top_hit = result.stdout.split('\n')[0].split('\t')
        human_gene = top_hit[1]
        identity = float(top_hit[2])
        evalue = float(top_hit[10])
        
        # BLAST human protein back to Pf (bidirectional)
        reverse_result = subprocess.run([
            "blastp", "-query", f"human_sequences/{human_gene}.fasta",
            "-db", "pf_db", "-evalue", "1e-10", "-outfmt", "6"
        ], capture_output=True, text=True)
        
        if reverse_result.stdout:
            reverse_hit = reverse_result.stdout.split('\n')[0].split('\t')
            reverse_gene = reverse_hit[1]
            
            # Reciprocal BLAST hit confirms orthology
            if reverse_gene == gene:
                orthologs.append({
                    'pf_gene': gene,
                    'human_gene': human_gene,
                    'identity': identity,
                    'evalue': evalue
                })

orthologs_df = pd.DataFrame(orthologs)
print(f"Found {len(orthologs_df)} potential human orthologs")

# Step 3.3: Assess target druggability
print("\nAssessing druggability scores...")

druggability_scores = []
for gene in orthologs_df['pf_gene'].tolist():
    pf_seq = SeqIO.read(f"sequences/{gene}.fasta", "fasta")
    human_seq = SeqIO.read(f"human_sequences/{orthologs_df[orthologs_df['pf_gene']==gene]['human_gene'].values[0]}.fasta", "fasta")
    
    # Druggability assessment (protein size, domain count, pocket volume, sequence complexity)
    pf_seq_len = len(pf_seq.seq)
    human_seq_len = len(human_seq.seq)
    
    # Count domains using InterPro predictions
    pf_domains = subprocess.run([
        "python", "-m", "interproscan.py", "-i", f"sequences/{gene}.fasta",
        "-T", "xml", "-o", f"interpro_{gene}.xml"
    ], capture_output=True, text=True)
    
    # Calculate druggability metrics
    size_score = max(0, min(1, (pf_seq_len - 200) / 300))  # Optimal size 200-500 aa
    sequence_complexity = len(set(pf_seq.seq)) / 20  # Amino acid diversity
    
    # Estimate binding pocket volume (simplified - based on structure)
    pf_structure = f"structures/{gene}.pdb"
    if os.path.exists(pf_structure):
        parser = PDBParser(QUIET=True)
        struct = parser.get_structure(gene, pf_structure)
        n_atoms = sum(1 for model in struct for chain in model for residue in chain for atom in residue)
        pocket_volume_score = min(1, n_atoms / 5000)  # Pocket volume proxy
    else:
        pocket_volume_score = 0.5
    
    druggability_score = (size_score + sequence_complexity + pocket_volume_score) / 3
    
    druggability_scores.append({
        'pf_gene': gene,
        'druggability_score': druggability_score,
        'pf_protein_size': pf_seq_len,
        'human_ortholog_size': human_seq_len,
        'sequence_complexity': sequence_complexity
    })

druggability_df = pd.DataFrame(druggability_scores)
print(f"Druggability assessment complete: mean score {druggability_df['druggability_score'].mean():.2f}")

# Step 3.4: Calculate selectivity index (Pf specificity vs human)
selectivity_assessment = []
for idx, row in orthologs_df.iterrows():
    pf_gene = row['pf_gene']
    human_gene = row['human_gene']
    identity = row['identity']
    
    # Lower identity = higher selectivity potential
    selectivity_index = max(0, 100 - identity)  # 0-100 scale
    
    # Penalize for conserved domains
    if identity > 80:
        selectivity_index *= 0.5  # Highly conserved - harder to target selectively
    
    selectivity_assessment.append({
        'pf_gene': pf_gene,
        'human_gene': human_gene,
        'identity': identity,
        'selectivity_index': selectivity_index
    })

selectivity_df = pd.DataFrame(selectivity_assessment)

# Step 3.5: Filter for high-priority targets
print("\n=== TARGET PRIORITIZATION ===")

# Combine druggability and selectivity scores
target_rankings = orthologs_df.merge(
    druggability_df, on='pf_gene'
).merge(
    selectivity_df, on='pf_gene'
)

# Prioritize: high selectivity (>50) + good druggability (>0.6)
target_rankings['priority_score'] = (
    target_rankings['selectivity_index'] * 0.5 +  # Selectivity weight
    target_rankings['druggability_score'] * 100 * 0.5  # Druggability weight
)

priority_targets = target_rankings.nlargest(5, 'priority_score')

print("\nTop 5 Priority Targets:")
print(priority_targets[['pf_gene', 'human_gene', 'selectivity_index', 'druggability_score', 'priority_score']].to_string(index=False))

# Step 3.6: Validate targets against artemisinin resistance
print("\nValidating targets against artemisinin resistance...")

# Check if any targets are differentially expressed in resistant strains
resistance_expression_file = "resistant_strain_transcriptomics.csv"
if os.path.exists(resistance_expression_file):
    expression_df = pd.read_csv(resistance_expression_file)
    
    for target_gene in priority_targets['pf_gene'].tolist():
        if target_gene in expression_df['gene_id'].values:
            fold_change = expression_df[expression_df['gene_id'] == target_gene]['log2_fold_change'].values[0]
            pvalue = expression_df[expression_df['gene_id'] == target_gene]['pvalue'].values[0]
            
            if abs(fold_change) < 1 and pvalue > 0.05:
                print(f"✓ {target_gene}: Stable expression in resistant strains (FC={fold_change:.2f}, p={pvalue:.3f})")
            else:
                print(f"⚠ {target_gene}: Variable expression in resistant strains (FC={fold_change:.2f}, p={pvalue:.3f})")

print("\n✓ Target mining complete")
print(f"  - {len(priority_targets)} high-priority targets identified")
```

**OUTPUT SPECS**:
- Target rankings (CSV): gene ID, selectivity index, druggability score, priority score, human ortholog
- Top priority targets (JSON): gene name, selectivity rationale, binding pocket characteristics, drug-like properties
- Validation report: expression stability, resistance mutation absence, essential gene confirmation
- Expected: 3-5 validated targets with selectivity >50 and druggability >0.6

**VALIDATION SCRIPT**:

```python
# Validate target selection criteria
assert len(priority_targets) >= 3, "Insufficient priority targets identified"
assert (priority_targets['selectivity_index'] > 40).all(), "Selectivity criteria not met"
assert (priority_targets['druggability_score'] > 0.55).mean() > 0.6, "Druggability criteria not met"

# Validate targets are independent from artemisinin resistance pathway
artemisinin_binding_targets = ['ATP6', 'TCTP', 'Plasmepsin 1/2']
pf_genes_in_resistance = target_rankings[target_rankings['pf_gene'].isin(artemisinin_binding_targets)]
assert len(pf_genes_in_resistance) == 0, "Resistance pathway targets included - violates independence criterion"

print(f"✓ Target validation passed: {len(priority_targets)} targets meet criteria")
```

**SUCCESS CRITERIA**:
- ✅ Minimum 3 targets identified with selectivity index >50
- ✅ Druggability score >0.6 for all priority targets
- ✅ Targets confirmed as essential genes in Plasmodium
- ✅ Low sequence identity with human orthologs (<70% for non-essential targets)
- ✅ Targets not enriched in artemisinin resistance pathways

**NEXT STEP**: Design selective inhibitors against identified targets (STEP 4)

---

## STEP 4: New Inhibitor Design and Validation

**OBJECTIVE**: Design selective inhibitors against prioritized targets, optimize for drug-like properties, validate selectivity and resistance potential, prepare for preclinical development.

**INPUT SPECS**:
- Target structures and binding sites (from STEP 3)
- Compound libraries (ZINC, ChEMBL)
- Known antimalarial leads (artemisinins, quinine analogs, DHFR inhibitors)
- ADMET prediction models
- Resistance mutation data

**CODE BLOCK - Inhibitor Design**:

```python
from rdkit import Chem, DataStructs
from rdkit.Chem import AllChem, Crippen, Descriptors, Lipinski, Filters
import subprocess
import requests

print("=== INHIBITOR DESIGN & OPTIMIZATION ===")

# Step 4.1: Define target binding sites and pharmacophores
priority_targets_list = priority_targets['pf_gene'].tolist()

for target_gene in priority_targets_list[:3]:  # Design for top 3 targets
    target_structure = f"structures/{target_gene}_alphafold.pdb"
    
    # Parse structure to identify binding pocket
    parser = PDBParser(QUIET=True)
    struct = parser.get_structure(target_gene, target_structure)
    
    # Identify conserved residues in active site (from sequence analysis)
    # [Define binding pocket manually based on domain architecture]
    
    # Step 4.2: Virtual screening against ZINC database
    print(f"\nScreening compounds for {target_gene}...")
    
    # Download ZINC compounds (pre-filtered for drug-like properties)
    zinc_compounds = "ZINC_lead_like.sdf"  # 3 million compounds pre-filtered
    
    # Prepare receptor PDBQT
    receptor_pdbqt = f"{target_gene}_receptor.pdbqt"
    subprocess.run([
        "prepare_receptor4.py", "-r", target_structure,
        "-o", receptor_pdbqt
    ], capture_output=True)
    
    # Screen compounds using molecular docking
    docking_results_target = []
    
    suppl = Chem.SDMolSupplier(zinc_compounds, removeHs=False)
    for i, mol in enumerate(suppl):
        if mol is None or i > 10000:  # Screen subset for speed
            continue
        
        # Convert to 3D if needed
        if mol.GetNumConformers() == 0:
            mol = Chem.AddHs(mol)
            AllChem.EmbedMolecule(mol, randomSeed=42)
            AllChem.MMFFOptimizeMolecule(mol)
        
        # Dock using Vina
        mol_file = f"temp_compound_{i}.pdb"
        ligand_pdbqt = mol_file.replace('.pdb', '.pdbqt')
        
        # Write molecule
        writer = Chem.SDWriter(mol_file)
        writer.write(mol)
        writer.close()
        
        # Prepare ligand
        subprocess.run([
            "prepare_ligand4.py", "-l", mol_file,
            "-o", ligand_pdbqt
        ], capture_output=True)
        
        # Dock
        dock_output = f"dock_{i}.pdbqt"
        result = subprocess.run([
            "vina", "--receptor", receptor_pdbqt,
            "--ligand", ligand_pdbqt,
            "--center_x", "42.0", "--center_y", "15.5", "--center_z", "31.0",
            "--size_x", "30", "--size_y", "30", "--size_z", "30",
            "--exhaustiveness", "8", "--out", dock_output
        ], capture_output=True, text=True)
        
        # Parse affinity
        for line in result.stdout.split('\n'):
            if 'RESULT:' in line:
                affinity = float(line.split()[2])
                if affinity < -7.0:  # Threshold for promising hits
                    zinc_id = Chem.MolToSmiles(mol)
                    docking_results_target.append({
                        'compound_id': i,
                        'zinc_id': zinc_id,
                        'affinity_kcal_mol': affinity,
                        'target': target_gene
                    })
    
    # Step 4.3: Predict ADMET properties for hits
    print(f"Evaluating ADMET for {len(docking_results_target)} hits...")
    
    admet_data = []
    for result in docking_results_target:
        smiles = result['zinc_id']
        mol = Chem.MolFromSmiles(smiles)
        
        if mol is None:
            continue
        
        # Lipinski's Rule of Five
        mw = Descriptors.MolWt(mol)
        logp = Crippen.MolLogP(mol)
        hbd = Descriptors.NumHDonors(mol)
        hba = Descriptors.NumHAcceptors(mol)
        
        lipinski_violations = sum([
            mw > 500,
            logp > 5,
            hbd > 5,
            hba > 10
        ])
        
        # Predict metabolic stability (CYP3A4 substrate prediction)
        cyp3a4_substrate_prob = predict_cyp3a4_substrate(mol)  # Custom ML model
        
        # Predict blood-brain barrier permeability
        bbb_penetrant = (mw < 400) and (logp < 2.5)  # Simplified BBB model
        
        # Predict plasma protein binding
        ppb = predict_plasma_protein_binding(mol)  # Custom model
        
        admet_data.append({
            'compound_id': result['compound_id'],
            'smiles': smiles,
            'target': target_gene,
            'affinity_kcal_mol': result['affinity_kcal_mol'],
            'mw': mw,
            'logp': logp,
            'hbd': hbd,
            'hba': hba,
            'lipinski_violations': lipinski_violations,
            'cyp3a4_substrate': cyp3a4_substrate_prob,
            'bbb_penetrant': bbb_penetrant,
            'ppb': ppb
        })
    
    admet_df = pd.DataFrame(admet_data)
    
    # Step 4.4: Filter for drug-like properties
    drug_like_compounds = admet_df[
        (admet_df['lipinski_violations'] <= 1) &
        (admet_df['cyp3a4_substrate'] < 0.7) &  # Avoid rapid metabolism
        (admet_df['ppb'] < 95)  # Adequate bioavailability
    ].nlargest(10, 'affinity_kcal_mol')
    
    print(f"✓ {len(drug_like_compounds)} drug-like compounds identified for {target_gene}")
    
    # Step 4.5: Design potency optimizations (scaffold hopping, substituent optimization)
    print(f"Optimizing scaffolds...")
    
    lead_compound = drug_like_compounds.iloc[0]
    lead_smiles = lead_compound['smiles']
    lead_mol = Chem.MolFromSmiles(lead_smiles)
    
    # Identify core scaffold
    from rdkit.Chem.Scaffolds import MurckoScaffold
    scaffold = MurckoScaffold.GetScaffoldForMol(lead_mol)
    
    # Enumerate analogs with varied substituents
    analogs_generated = []
    substituents = [
        '[F]', '[Cl]', '[Br]', '[I]',  # Halogens
        '[OH]', '[NH2]', '[CN]',  # Polar groups
        '[OCH3]', '[N(CH3)2]'  # Methyl-containing
    ]
    
    # [Generate and dock analogs]
    # For efficiency, use chemistry heuristics instead of full docking
    
    # Step 4.6: Assess selectivity vs off-targets
    print(f"Assessing selectivity...")
    
    # Screen lead compound against human orthologs
    human_orthologs_to_test = [
        ('DHFR', 'human_DHFR.pdb'),
        ('TS', 'human_TS.pdb'),
        ('FPGS', 'human_FPGS.pdb')
    ]
    
    selectivity_scores = []
    for human_gene, human_pdb in human_orthologs_to_test:
        # Dock lead compound to human targets
        human_affinity = dock_molecule(lead_smiles, human_pdb)
        pf_affinity = lead_compound['affinity_kcal_mol']
        
        selectivity = human_affinity - pf_affinity  # Positive = selective for Pf
        selectivity_scores.append({
            'target': target_gene,
            'off_target': human_gene,
            'pf_affinity': pf_affinity,
            'human_affinity': human_affinity,
            'selectivity_delta_g': selectivity,
            'selectivity_fold': 2**(selectivity/1.36)
        })
    
    selectivity_summary_df = pd.DataFrame(selectivity_scores)
    
    # Step 4.7: Validate resistance development potential
    print(f"Assessing resistance evolution potential...")
    
    # Identify potential resistance mutations based on previous resistance patterns
    potential_resistance_sites = identify_resistance_sites(target_gene)
    
    # Mutagenize and dock
    resistance_vulnerability = 0
    for res_pos in potential_resistance_sites:
        # Try single mutations at resistance site
        for mut_aa in 'ACDEFGHIKLMNPQRSTVWY':
            mutant_affinity = compute_affinity_mutant(lead_smiles, target_gene, res_pos, mut_aa)
            affinity_loss = lead_compound['affinity_kcal_mol'] - mutant_affinity
            
            if affinity_loss > 2.0:  # >10-fold loss indicates high resistance risk
                resistance_vulnerability += 1
    
    resistance_risk = resistance_vulnerability / len(potential_resistance_sites) if potential_resistance_sites else 0
    
    print(f"Resistance risk score: {resistance_risk:.2f} (0=low risk, 1=high risk)")

# Step 4.8: Generate final lead compound report
print("\n=== FINAL LEAD COMPOUNDS ===")

leads_summary = []
for target_gene in priority_targets_list[:3]:
    # Retrieve best compound for each target
    best_compound = get_best_compound_for_target(target_gene)
    
    leads_summary.append({
        'target': target_gene,
        'lead_compound': best_compound['smiles'],
        'affinity_nM': best_compound['affinity_nM'],
        'selectivity_vs_human': best_compound['selectivity_ratio'],
        'resistance_risk': best_compound['resistance_risk'],
        'mw': best_compound['mw'],
        'logp': best_compound['logp'],
        'status': 'Ready for synthesis and validation'
    })

leads_df = pd.DataFrame(leads_summary)
print(leads_df.to_string(index=False))

print("\n✓ Inhibitor design complete")
```

**OUTPUT SPECS**:
- Lead compounds (SDF/SMILES): top 3-5 compounds per target with 3D coordinates
- Docking results (CSV): compound ID, SMILES, target, affinity, ADMET properties, selectivity scores
- Selectivity assessment (JSON): off-target screening results, selectivity ratios vs human orthologs
- Resistance vulnerability analysis (CSV): potential resistance sites, mutation impact on binding
- Expected: 3-5 lead compounds with affinity <10 nM, selectivity >50-fold, resistance risk <0.3

**VALIDATION SCRIPT**:

```python
# Validate lead compound selection
assert len(leads_df) >= 2, "Insufficient lead compounds identified"

# Validate affinity and selectivity
for idx, row in leads_df.iterrows():
    pf_affinity = row['affinity_nM']
    selectivity = row['selectivity_vs_human']
    
    assert pf_affinity < 100, f"Affinity {pf_affinity} nM exceeds target (<100 nM)"
    assert selectivity > 10, f"Selectivity {selectivity} too low (<10-fold minimum)"
    assert row['mw'] < 600, f"Molecular weight {row['mw']} violates Lipinski's rule"

# Validate resistance risk assessment
assert (leads_df['resistance_risk'] < 0.5).mean() > 0.5, "High resistance risk for leads"

print(f"✓ Lead compound validation passed")
print(f"  - {len(leads_df)} compounds meet efficacy (affinity <100 nM) + selectivity (>10-fold)")
print(f"  - Average resistance risk: {leads_df['resistance_risk'].mean():.2f}")
```

**SUCCESS CRITERIA**:
- ✅ Minimum 2 lead compounds identified per target
- ✅ Binding affinity <100 nM for priority targets
- ✅ Selectivity >10-fold vs human orthologs
- ✅ ADMET properties favorable (Lipinski compliance, BBB penetrant or target allows)
- ✅ Resistance risk assessment completed

---

## Troubleshooting Guide

| Problem | Root Cause | Solution |
|---------|-----------|----------|
| **Low mutation discovery rate** | Insufficient resistant strains or low sequencing depth | Expand strain collection to 100+ resistant isolates, use WGS with ≥50× coverage, include multiple geographic regions |
| **Poor BLAST alignment** | Reference sequence divergence or sequence quality issues | Use strain-specific reference genomes, validate with Sanger sequencing for key mutations, filter low-quality reads (Q>30) |
| **Docking convergence failure** | Binding site misconfiguration or ligand preparation errors | Verify binding site coordinates with experimental data (if available), ensure proper PDBQT conversion (check for missing atoms), increase exhaustiveness parameter (8→16) |
| **Selectivity loss vs human ortholog** | High sequence conservation in binding pocket | Design allosteric inhibitors instead of orthosteric (target adjacent allosteric sites), incorporate selectivity filters early in screening |
| **Virtual screening inefficiency** | Database too large or scoring function mismatch | Use pre-filtered ZINC databases (lead-like or drug-like subsets), validate scoring with known actives first, parallelize docking across GPU clusters |

## Resource Requirements

| Resource | Specification | Justification |
|----------|---------------|---------------|
| **Compute (CPU)** | 16-24 cores | Parallel BLAST searches (8+ cores), phylogenetic tree construction (8+ cores), virtual screening batch processing |
| **Memory (RAM)** | 64-128 GB | In-memory storage of genomic databases, structure coordinates, docking trajectories |
| **Storage** | 400 GB | ZINC database (~50 GB), Plasmodium genome assemblies (~100 GB), PDB structures (~20 GB), intermediate results (~230 GB) |
| **GPU** | 2× Tesla V100 (optional) | GROMACS MD simulations (2-4× speedup), deep learning for ADMET prediction |
| **Runtime** | 8-12 weeks | BLAST/phylogenetics: 1-2 weeks; docking setup: 1 week; virtual screening: 4-6 weeks; analysis/optimization: 2-3 weeks |
| **Cost Estimate** | $15,000-22,000 | HPC node-hours ($5K-8K), software licenses ($3K-5K), database access ($2K-3K), personnel time ($5K-6K) |

## Tool Installation Matrix

| Tool | Version | Install Command | Purpose |
|------|---------|-----------------|---------|
| BLAST | 2.14.0+ | `conda install -c bioconda blast` | Sequence similarity searching, ortholog identification |
| RAxML | 8.2.12+ | `conda install -c bioconda raxml` | Phylogenetic tree construction from alignments |
| IQ-TREE | 2.2+ | `conda install -c bioconda iqtree` | Fast phylogenetic inference with model testing |
| AlphaFold2 | 2.3.0 | `git clone github.com/deepmind/alphafold` | 3D structure prediction for targets lacking PDB structures |
| AutoDock Vina | 1.2.3 | `conda install -c bioconda autodock-vina` | Molecular docking and virtual screening |
| FoldX | 5.0 | `download from foldxsuite.crg.es` | Rapid mutation effect prediction on binding/stability |
| Rosetta | 3.13+ | `conda install -c bioconda rosetta` | Protein design and structure-function optimization |
| GROMACS | 2021+ | `conda install -c conda-forge gromacs` | Molecular dynamics simulations for binding characterization |
| ProDy | 1.11+ | `pip install prody` | Structure analysis, normal mode analysis, conformational dynamics |
| ZINC Database | Current | Web API: `zinc.docking.org` | Virtual compound library for screening (15M+ compounds) |

## Example Walkthrough: Next-Generation Antimalarial for Artemisinin-Resistant Plasmodium

### Scenario
A research team aims to develop antimalarials effective against artemisinin-resistant Plasmodium falciparum strains from Southeast Asia. The team has access to 50 resistant parasite isolates and existing structural data for PfATPase6.

### Timeline & Milestones

| Week | Task | Output | Person-Hours |
|------|------|--------|--------------|
| 1-2 | STEP 1: Resistance mutation analysis from 50 strains | 120+ mutations, 10 hotspots identified | 80 |
| 3-4 | STEP 2: Artemisinin binding mode analysis via docking | Binding affinity + selectivity profiles | 100 |
| 5-8 | STEP 3: Target mining and prioritization | 5 novel targets ranked by selectivity | 120 |
| 9-12 | STEP 4: Virtual screening and lead optimization | 3 lead compounds with <100 nM affinity | 150 |
| 12 | **Total project duration: 12 weeks** | **4 validated lead compounds** | **450 person-hours** |

### Expected Outcomes

- **Mutation Database**: 120+ unique mutations, with L263E/K (80% resistant strains), S769N (35%), E1312K (25%)
- **New Targets Identified**: 
  - PfATP1: Selectivity index 78, druggability 0.78 (potential IP2-mediated drug escape pathway)
  - PfPK7: Selectivity index 65, druggability 0.71 (calcium-dependent signaling)
  - PfPDE1δ: Selectivity index 82, druggability 0.75 (prenylation-dependent parasite survival)
- **Lead Compounds**:
  - Compound 1 (anti-PfATP1): Affinity 45 nM, selectivity 92-fold vs human ATP1, resistance risk 0.18
  - Compound 2 (anti-PfPK7): Affinity 78 nM, selectivity 65-fold vs human PK7, resistance risk 0.22
  - Compound 3 (anti-PfPDE1δ): Affinity 92 nM, selectivity 78-fold vs human PDE1δ, resistance risk 0.19
- **Resistance Potential**: <0.25 (low), due to target selection independent from artemisinin pathway
- **Timeline**: 12 weeks from sequences to lead synthesis
- **Next Steps**: Synthetic confirmation, cell-based validation (IC₅₀ <5 μM on resistant parasites), pharmacokinetics

---

## Success Checklist

### Pre-Analysis Planning
- [ ] **Strain collection confirmed**: ≥20 artemisinin-resistant isolates from multiple geographic regions
- [ ] **Sequencing data obtained**: Whole-genome or targeted ATP6 sequencing, ≥30× coverage, Q-score >30
- [ ] **Reference genomes available**: PfATPase6 (GenBank PF3D7_0323200), human ATP synthase (Ensembl ENSG00000004529)
- [ ] **Computational resources allocated**: 16+ CPU cores, 64+ GB RAM, GPU cluster access (optional)

### STEP 1 Validation
- [ ] **BLAST search successful**: Aligned 100+ resistant genomes to PfATPase6 reference
- [ ] **Mutations called accurately**: Manual verification of 5-10 mutations by Sanger sequencing
- [ ] **Hotspot positions identified**: Entropy analysis reveals 5-15 mutation-enriched positions
- [ ] **Phylogenetic tree constructed**: Resistant strains cluster by geographic origin/phenotype
- [ ] **Known resistance mutations present**: L263E, L263K, S769N found in >20% of strains

### STEP 2 Validation
- [ ] **Docking parameters optimized**: Binding site verified with known substrate coordinates
- [ ] **Artemisinin affinity calculated**: Wildtype PfATPase6 Ki <1000 nM (literature range 100-1000 nM)
- [ ] **Resistance mutations show binding loss**: ≥0.5 kcal/mol affinity decrease for known resistance mutations
- [ ] **Selectivity confirmed**: >100-fold selectivity for Pf vs human ATP synthase (wildtype)
- [ ] **Binding poses visualized**: Top 3 poses assessed for chemical logic

### STEP 3 Validation
- [ ] **Essential genes identified**: ≥50 confirmed essential genes from PlasmoDB/literature
- [ ] **Human orthologs mapped**: Bidirectional BLAST confirms 80%+ of Pf genes have human orthologs
- [ ] **Druggability assessed**: Scoring includes protein size, domain count, pocket volume
- [ ] **Selectivity calculated**: Top 10 targets show identity <70% with human orthologs
- [ ] **Target novelty confirmed**: No overlap with known artemisinin resistance genes (ATP6, TCTP, plasmepsins)

### STEP 4 Validation
- [ ] **Virtual screening completed**: ≥1000 compounds docked to each priority target
- [ ] **Lead compounds identified**: ≥2 compounds per target with affinity <100 nM
- [ ] **ADMET favorable**: Lipinski compliance (≤1 violation), metabolic stability, appropriate BBB penetrance
- [ ] **Selectivity confirmed**: ≥10-fold selectivity vs human orthologs for lead compounds
- [ ] **Resistance risk low**: <0.3 vulnerability score, no obvious escape mutations at binding site

### Final Output
- [ ] **Novel targets published/filed**: 3-5 new antimalarial targets with IP protection
- [ ] **Lead compounds ready for synthesis**: 3-5 compounds with docking poses, SMILES, predicted activity
- [ ] **Mechanistic understanding established**: Clear connection between target function and parasite survival
- [ ] **Preclinical plan approved**: Team consensus on cell-based and in vivo validation strategy
- [ ] **Funding secured or submitted**: Grant applications highlighting novel mechanism

---

## Final Experimental Product

**Next-generation antimalarials** with:
- ✅ New mechanisms of action independent of artemisinin pathway
- ✅ Predicted efficacy against artemisinin-resistant strains
- ✅ High selectivity for Plasmodium (>10-50 fold vs human)
- ✅ Drug-like properties suitable for development
- ✅ Low predicted resistance potential
- ✅ Ready for synthesis, cell-based validation, and preclinical efficacy testing
- ✅ Potential to overcome global artemisinin resistance crisis

---

## Key Computational Tools

- **Sequence analysis**: BLAST, HMMsearch, Biopython
- **Phylogenetic analysis**: RAxML, IQ-TREE, FigTree
- **Structure prediction**: AlphaFold2, I-TASSER, Rosetta
- **Molecular docking**: AutoDock Vina, Glide, DOCK6
- **Binding affinity**: MM-PBSA, MM-GBSA, FoldX, Rosetta
- **Selectivity analysis**: Structure alignment, SIFT, PolyPhen
- **Virtual screening**: ZINC database, SMINA, custom Python pipelines
- **ADMET prediction**: ADMET SAR, pkCSM, DeepChem, RDKit
- **Molecular dynamics**: GROMACS, AMBER, NAMD
- **Visualization**: PyMOL, Chimera, VMD, Plotly
